1. Can Event-Related Potential Predict the Progression of Mild Cognitive Impairment?
- Author
-
Jacques Touchon, Karim Bennys, Gérard Rondouin, Elise Benattar, and Audrey Gabelle
- Subjects
Male ,medicine.medical_specialty ,Physiology ,Neuropsychological Tests ,Audiology ,behavioral disciplines and activities ,Predictive Value of Tests ,Event-related potential ,Physiology (medical) ,mental disorders ,P3b ,Healthy control ,Reaction Time ,medicine ,Humans ,Cognitive Dysfunction ,In patient ,Cognitive impairment ,Evoked Potentials ,Aged ,Aged, 80 and over ,Analysis of Variance ,business.industry ,Predictive value ,Electric Stimulation ,Acoustic Stimulation ,ROC Curve ,Neurology ,Disease Progression ,Female ,Neurology (clinical) ,Mental Status Schedule ,business ,Follow-Up Studies - Abstract
This study was designed to evaluate the predictive value of event-related potential (ERP; N2 and P3b) in patients with mild cognitive impairment (MCI). Seventy-one patients with MCI were selected and compared with 31 healthy control subjects. They benefited from an initial assessment that included a neuropsychological evaluation and ERP. We followed them up for 1 year, and during their last visit, they benefited again from ERP and neuropsychological tests. At the end of the study, 2 subgroups of patients with MCI were differentiated according to their clinical evolution from baseline to follow-up: 41 MCI progressors (MCI-P) and 30 MCI nonprogressors (MCI-non P). The MCI-P patients had a significant decline in their executive functions compared with the MCI-non-P group at baseline and follow-up especially on trail making test B (TMT B) and verbal fluency (P0.0001). At baseline, MCI-P had increased P3b latencies and low P3b amplitudes compared with MCI-non P. The MCI-P showed an inversion of the P3b rostrocaudal gradient with a significant decrease in the amplitude of P3b in the parietal area compared with the MCI-non P. At follow-up, 17 MCI-P patients had converted to Alzheimer's disease (AD). There was a significant rate of decline of the amplitude of N2 and P3b in the frontal area among the groups. Furthermore, the MCI-P had a higher decrease in the rostrocaudal gradient of P3b and prolonged N2 and P3b latencies than the MCI-non P did. The sensitivity and specificity were approximately 80% and 70%, using P3b amplitude to discriminate the MCI-P from the MCI-non P. Our study underlines the interest of using N2 and P3b as neurophysiological markers for measuring MCI decline progression.
- Published
- 2011